Paul Tappenden

16PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersEconometric and statistical methodsGene and molecular therapyRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 11, 2025
Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation.

Paul Tappenden, Katy Cooper, Jean Hamilton

|Aug 06, 2024
Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling.

Johanna Lister, Suzy Paisley, Christopher Carroll

|May 31, 2024
A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies.

Paul Tappenden, Orla Hardiman, Sun-Hong Kwon

|Jan 17, 2023
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK.

Paul Tappenden, Aline Navega Biz, Mónica Hernández Alava

|Jan 06, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

Peter Murphy, David Glynn, Sofia Dias

|May 19, 2021
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals.

Tushar Srivastava, Nicholas R Latimer, Paul Tappenden

Pageof 3

Frequent Collaborators

4 joint publications

Katy Cooper

3 joint publications

Ruth Wong

2 joint publications

Jean Hamilton

2 joint publications

Kate Ennis